In:
International Journal of Technology Assessment in Health Care, Cambridge University Press (CUP), Vol. 15, No. 1 ( 1999-01), p. 161-172
Abstract:
Using the example of substitution of peripheral blood stem cell (PBSC)
collection to bone marrow harvest for autologous transplantation in cancer patients, our study attempts to illustrate how economic assessment, starting
at an early stage of medical innovation, can influence the development and diffusion process of a new technological procedure whose optimal design has
not yet been established. Two cost minimization studies comparing costs for obtaining a clinically reinfusable graft using bone marrow harvest or
alternatively various protocols of PBSC collection contributed to a change in the French clinical standard for this procedure.
Type of Medium:
Online Resource
ISSN:
0266-4623
,
1471-6348
DOI:
10.1017/S0266462399152450
Language:
English
Publisher:
Cambridge University Press (CUP)
Publication Date:
1999
detail.hit.zdb_id:
2020486-3
